tiprankstipranks
Advertisement
Advertisement

DRTS Stock Latest News

Alpha Tau price target raised to $16 from $15 at H.C. Wainwright
The FlyAlpha Tau price target raised to $16 from $15 at H.C. Wainwright
11d ago
DRTS
Alpha Tau Medical Updates Investors With H1 2026 Financials in New Form 6-K Filing
PremiumCompany Announcements
Alpha Tau Medical Updates Investors With H1 2026 Financials in New Form 6-K Filing
12d ago
6K
DRTS
Alpha Tau reports Q2 EPS (25c), consensus (14c)
PremiumThe Fly
Alpha Tau reports Q2 EPS (25c), consensus (14c)
12d ago
DRTS
Alpha Tau Medical Registers for Dual Listing on Tel Aviv Stock Exchange
PremiumCompany Announcements
Alpha Tau Medical Registers for Dual Listing on Tel Aviv Stock Exchange
12d ago
6K
DRTS
Alpha Tau’s Cancer Combination Just Delivered a Response Rate More Than 5X Keytruda’s Historical Benchmark
PremiumTipRanks Newswire
Alpha Tau’s Cancer Combination Just Delivered a Response Rate More Than 5X Keytruda’s Historical Benchmark
24d ago
DRTS
Alpha Tau reports Alpha DaRT combination study results
PremiumThe FlyAlpha Tau reports Alpha DaRT combination study results
1M ago
DRTS
Alpha Tau Posts Strong Alpha DaRT–Keytruda Data in Head and Neck Cancer Study
Premium
Company Announcements
Alpha Tau Posts Strong Alpha DaRT–Keytruda Data in Head and Neck Cancer Study
1M ago
6K
DRTS
Alpha Tau treats first patient in ADMIRE study for recurrent skin cancer
Premium
The Fly
Alpha Tau treats first patient in ADMIRE study for recurrent skin cancer
1M ago
DRTS
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
BBD
IRE
Alpha Tau Medical Shareholders Back Board, CEO Dual Role and Auditor at June 2026 AGM
PremiumCompany Announcements
Alpha Tau Medical Shareholders Back Board, CEO Dual Role and Auditor at June 2026 AGM
2M ago
6K
DRTS
Alpha Tau Medical Continues Its Winning Streak with First-Ever Brain-Cancer Patient Treated Outside the U.S.
PremiumTipRanks Newswire
Alpha Tau Medical Continues Its Winning Streak with First-Ever Brain-Cancer Patient Treated Outside the U.S.
2M ago
DRTS
Alpha Tau Treats First Recurrent Glioblastoma Patient Outside U.S. With Alpha DaRT in Israel
PremiumCompany Announcements
Alpha Tau Treats First Recurrent Glioblastoma Patient Outside U.S. With Alpha DaRT in Israel
2M ago
6K
DRTS
Alpha Tau treats first glioblastoma patient in Israel with Alpha DaRT
PremiumThe FlyAlpha Tau treats first glioblastoma patient in Israel with Alpha DaRT
2M ago
DRTS
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
SLS
AMPG
Alpha Tau gets FDA clearance to complete enrollment in REGAIN trial
Premium
The Fly
Alpha Tau gets FDA clearance to complete enrollment in REGAIN trial
2M ago
DRTS
Alpha Tau Wins FDA Clearance to Complete REGAIN Glioblastoma Trial Enrollment After Strong Interim Data
PremiumCompany Announcements
Alpha Tau Wins FDA Clearance to Complete REGAIN Glioblastoma Trial Enrollment After Strong Interim Data
2M ago
6K
DRTS
Alpha Tau price target raised to $17 from $15 at Barclays
PremiumThe Fly
Alpha Tau price target raised to $17 from $15 at Barclays
3M ago
DRTS
Alpha Tau, Tolmar announce strategic collaboration agreement
PremiumThe Fly
Alpha Tau, Tolmar announce strategic collaboration agreement
3M ago
DRTS
Alpha Tau Strikes 20-Year U.S. Prostate Cancer Commercialization and $20 Million Equity Deal With Tolmar
PremiumCompany Announcements
Alpha Tau Strikes 20-Year U.S. Prostate Cancer Commercialization and $20 Million Equity Deal With Tolmar
3M ago
6K
DRTS
Alpha Tau Buy Rating Reiterated as Encouraging Pancreatic Data Support Maintained $15 Price Target
PremiumRatingsAlpha Tau Buy Rating Reiterated as Encouraging Pancreatic Data Support Maintained $15 Price Target
3M ago
DRTS
Alpha Tau reports positive survival data from pancreatic cancer study
Premium
The Fly
Alpha Tau reports positive survival data from pancreatic cancer study
3M ago
DRTS
Alpha Tau Posts Strong Pancreatic Cancer Survival Data for Alpha DaRT at 2026 ASCO
Premium
Company Announcements
Alpha Tau Posts Strong Pancreatic Cancer Survival Data for Alpha DaRT at 2026 ASCO
3M ago
6K
DRTS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >